Yamamoto M, Hibi H, Tsuji Y, Miyake K
Department of Urology, Nagoya University School of Medicine, Japan.
Nagoya J Med Sci. 1994 Dec;57(3-4):119-26.
The effects of protein synthesis inhibition and disassembly of microtubules in the epididymal epithelia on proluminal movement of 3H-androgens were investigated by using in vivo microperifusion of 3H-testosterone and subsequent micropuncture to obtain peritubular and intraluminal fluids of caput epididymal tubules. Cycloheximide (100 micrograms/ml) was used as protein synthesis inhibitor. Nocodazole (3 micrograms/ml) was used to depolymerize microtubules in the cell. The perifusion fluid was Minimum Essential Medium containing 26.7 microCi/ml 3H-testosterone and 1.3 microCi/ml 14C-polyethyleneglycol (14C-PEG), or the same fluid supplemented with cycloheximide or nocodazole. Radioactivity of 3H-androgen and 14C-PEG in perifusion and intraluminal fluids was determined at one hour after initiation of the sustaining perifusion, and the percentage of radioactivity of 3H-androgen and 14C-PEG appearing in the intraluminal fluid to that in the peritubular fluid was determined. Proluminal movement of 3H-androgens into the caput epididymal tubules in the control rats was 323.4 +/- 73.2%. This value was significantly reduced to 121.8 +/- 13% by addition of cycloheximide to the perifusion fluid (p < 0.01). Transepithelial movement of 3H-androgen in the caput epididymis was significantly decreased to 86.6 +/- 5.3% by exposure of the epididymal tubules to nocodazole (p < 0.01). Inhibition of protein synthesis and disassembly of microtubules in the epididymal epithelial cells completely eliminated antigrade proluminal movement of 3H-androgen into the tubules. Study of the incorporation of 35S-Methionine into epididymal tissue protein revealed significant reduction of the quantity of radiolabeled proteins in the perifused tissue with fluid containing cycloheximide (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
通过对3H-睾酮进行体内微量灌注以及随后的微穿刺以获取附睾头小管的管周液和管腔内液,研究了附睾上皮中蛋白质合成抑制和微管解聚对3H-雄激素向管腔移动的影响。环己酰亚胺(100微克/毫升)用作蛋白质合成抑制剂。诺考达唑(3微克/毫升)用于使细胞中的微管解聚。灌注液为含有26.7微居里/毫升3H-睾酮和1.3微居里/毫升14C-聚乙二醇(14C-PEG)的最低必需培养基,或添加了环己酰亚胺或诺考达唑的相同液体。在维持灌注开始1小时后测定灌注液和管腔内液中3H-雄激素和14C-PEG的放射性,并测定管腔内液中3H-雄激素和14C-PEG的放射性与管周液中放射性的百分比。对照大鼠中3H-雄激素向附睾头小管的管腔移动为323.4±73.2%。通过向灌注液中添加环己酰亚胺,该值显著降低至121.8±13%(p<0.01)。通过将附睾小管暴露于诺考达唑,附睾头中3H-雄激素的跨上皮移动显著降低至86.6±5.3%(p<0.01)。附睾上皮细胞中蛋白质合成的抑制和微管的解聚完全消除了3H-雄激素向小管的顺行性管腔移动。对35S-甲硫氨酸掺入附睾组织蛋白的研究表明,用含有环己酰亚胺的液体灌注的组织中放射性标记蛋白的量显著减少(p<0.01)。(摘要截短至250字)